RECRUITING

Functional Endoscopic Sinus Surgery Study

Description

The aim of this study is to evaluate the effect of the addition of epinephrine to bilateral real time ultrasound guided pterygopalatine ganglion blocks on intra-operative bleeding and blood loss during functional endoscopic sinus surgery (FESS).

Conditions

Chronic Rhinosinusitis (Diagnosis)
Talk to us

Related Conditions:

Chronic Rhinosinusitis (Diagnosis)

Study Overview

On this page

Study Details

Study overview

The aim of this study is to evaluate the effect of the addition of epinephrine to bilateral real time ultrasound guided pterygopalatine ganglion blocks on intra-operative bleeding and blood loss during functional endoscopic sinus surgery (FESS).

Does the Addition of Epinephrine to Bilateral Ultrasound Guided Pterygopalatine Ganglion Block Reduce Bleeding During Functional Endoscopic Sinus Surgery (FESS)? A Pilot Study

Functional Endoscopic Sinus Surgery Study

Condition
Chronic Rhinosinusitis (Diagnosis)
Intervention / Treatment

-

Contacts and Locations

Gainesville

UF Health of University of Florida, Gainesville, Florida, United States, 32610

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patient presenting for bilateral FESS
  • 2. Adult patients (\>18 and \< 90 years old)
  • 3. Patient consents to participate
  • 4. No underlying chronic pain condition
  • 5. No underlying bleeding diathesis
  • 1. Patient refuses to consent
  • 2. Patient requires revision or unilateral surgery
  • 3. Patient requires surgery in addition to FESS
  • 4. Age younger than 18 or older than 90 years
  • 5. Any underlying chronic pain condition
  • 6. History of bleeding diathesis
  • 7. Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement.
  • 8. Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation.
  • 9. Vulnerable patient population

Ages Eligible for Study

18 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Florida,

Cameron R Smith, PRINCIPAL_INVESTIGATOR, University of Florida

Study Record Dates

2026-12-15